---
uid: 20260215154800
title: Low-Carb Diets Restore Beta-Cell Function in Early T2D Reversal
authors: Tsoukalas (~2018) + Taylor
year: 2018
tags: [lit, dt-clinic, diabetes-type2, low-carb, beta-cell, reversal, insulin-resistance, calorie-restriction, ir-biomarker, phd-biomarker, vitD, adipic, gc-ms, metabolomics]
aliases: [LowCarb_BetaCell_T2D]
status: atomic-strong
parent-moc: [[55-MOCs/MOC_DT_Diabetes_T2D]] | [[22-Dashboards/PhD_IR_MOC]]
chain-next: [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]] | [[33-Atomic/CalorieRestriction_Reverses_T2D_20260215_019]]
confidence: high
cited_refs: [[66-Literature/Diabetes_Type2_Pathogenesis_Tsoukalas_20260215_003]], [[66-Literature/Refs/Refs_Taylor_Lancet_Reversal_032]]
---

# LowCarb_BetaCell_Recovery_20260215_024

**Strong Claim**: Low-carb reduces glucotoxicity → beta-cell recovery superior to meds in early T2D.

**Evidence** (Tsoukalas/Taylor): Chains with calorie Rx; PhD: Adipic ↑ post-LC.

**Implication**: Combine w/ VitD/adipic for IR reset.

[[33-Atomic/CalorieRestriction_Reverses_T2D_20260215_019]] → [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]].